Uganda: factory to boost ARV rollout

A new Ugandan pharmaceutical factory has begun producing antiretroviral medication drugs locally, something the government says will significantly increase the number of HIV-positive people accessing the life-prolonging drugs across the country and the East African region. The US$38 million factory is the first in Africa to produce full triple-therapy generic antiretroviral drugs (ARVs), and is based in a suburb in the south of the capital, Kampala.